ProShares Ultra 20+ Year Treasury (UBT) |
|
31.33 -0.9 (-2.79%)
|
06-26 19:45 |
|
Open: |
31.85 |
Pre. Close: |
32.23 |
|
High:
|
32.19 |
Low:
|
31.328 |
|
Volume:
|
40,604 |
Market Cap:
|
0(M) |
|
|
|
|
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index includes publicly-issued U.S. Treasury securities that have a remaining maturity greater than or equal to twenty years and have $300 million or more of outstanding face value, excluding amounts held by the Federal Reserve. The fund is non-diversified. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
32.23 - 32.4 |
32.4 - 32.54 |
|
Low:
|
30.93 - 31.12 |
31.12 - 31.28 |
|
Close:
|
31.02 - 31.34 |
31.34 - 31.62 |
|
Technical analysis |
as of: 2022-06-24 4:43:50 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 38.52  One year: 41.4 |
| Support: |
Support1: 29 Support2: 24.12 |
| Resistance: |
Resistance1: 32.98 Resistance2: 35.45 |
| Pivot: |
31.36 |
| Moving Average: |
MA(5): 31.29  MA(20): 31.97
MA(100): 39.03 MA(250): 48.06 |
| MACD: |
MACD(12,26): -0.9 Signal(9): -1.1 |
| Stochastic oscillator: |
%K(14,3): 61.4 %D(3): 50.1 |
| RSI: |
RSI(14): 44 |
| 52-week: |
High: 60 Low: 29 |
| Average Vol(K): |
3-Month: 46 (K) 10-Days: 52 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ UBT ] has closed above bottom band by 49.0%. Bollinger Bands are 28.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 21 Jun 2022
Dow University launches UBT to diagnose H. Pylori - The Nation
Sat, 18 Jun 2022
Gessert to lead downtown Lincoln Rotary 14 - Lincoln Journal Star
Mon, 13 Jun 2022
The Big Give to gift $1 million to local nonprofits - KOLN
Thu, 09 Jun 2022
Union Bank & Trust donates $1.5 million to new LPS football stadium - KLKN
Tue, 07 Jun 2022
Kaiser Permanente - Apply now for the new Alliance Partnership Representative Role - UFCW 21
Wed, 01 Jun 2022
Urea Breath Test Market to Surpass US$ 157.2 Million at a CAGR of 5.1% by 2028 | Mayoli Spindler (Kibion AB), Otsuka Pharmaceutical Co. Ltd., Sercon Group, Meridian Bioscience, Paladin Labs Inc., Beijing Richen- Force Science & Technology Co., Lt - Medgadget
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: |
| Industry: |
| Shares Out. |
0 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
